HealthSouth Corporation (HLS) has risen sharply, recording gains of 6.57% in the past 4 weeks. However, the stock has corrected -1.65% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 3.98% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
HealthSouth Corporation (NYSE:HLS): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $42.47 and $42.21 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $42.61. The buying momentum continued till the end and the stock did not give up its gains. It closed at $42.34, notching a gain of 0.33% for the day. The total traded volume was 590,079 . The stock had closed at $42.20 on the previous day.
The stock has recorded a 20-day Moving Average of 3.71% and the 50-Day Moving Average is 5.37%. HEALTHSOUTH Corp. is up 3.9% in the last 3-month period. Year-to-Date the stock performance stands at 23.13%.
HealthSouth Corporation (HLS) has been rated by 8 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $54 and the lowest price target forecast is $37. The average forecast of all the analysts is $47.13 and the expected standard deviation is $5.62.
HealthSouth Corporation (HealthSouth) is an owner and operator of inpatient rehabilitation hospitals. The Companys inpatient rehabilitation hospitals offer rehabilitative care across an array of diagnoses, which include physical and cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, head injuries, spinal cord injuries and a variety of debilitating neurological conditions. HealthSouth operates in around 33 states across the United States and in Puerto Rico and serves patients through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Companys inpatient rehabilitation hospitals offer rehabilitative care across an array of diagnoses. As of December 31, 2014, the Company operated 107 inpatient rehabilitation hospitals. The Companys inpatient hospitals are concentrated in the eastern half of the United States and Texas.